Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucie Peduto

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Current Pharmaceutical Design|July 16, 2009
ADAM9 as a potential target molecule in cancerLucie Peduto
Current Opinion in Immunology|May 11, 2020
Mesenchymal perivascular cells in immunity and diseaseAdam Benabid, Lucie Peduto
Cell Stem Cell|March 8, 2026
Neuronal VIP shapes intestinal stem cell activity and mucosal immunityCamilla Anastasio, Lucie Peduto
The Journal of Clinical Investigation|January 3, 2018
The perivascular origin of pathological fibroblastsSelene E Di Carlo, Lucie Peduto
Journal of Immunological Methods|January 21, 2015
An optimized protocol for isolating lymphoid stromal cells from the intestinal lamina propriaIgor Stzepourginski, Gérard Eberl, Lucie Peduto
Mucosal Immunology|January 28, 2023
Stromal regulation of the intestinal barrierMarvin Sylvestre, Selene E Di Carlo, Lucie Peduto
Nature Medicine|July 31, 2012
Lineage tracing and genetic ablation of ADAM12(+) perivascular cells identify a major source of profibrotic cells during acute tissue injurySophie Dulauroy, Selene E Di Carlo, Francina Langa, et al.
Cancer Research|October 19, 2005
Critical function for ADAM9 in mouse prostate cancerLucie Peduto, Victor E Reuter, David R Shaffer, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2017
CD34+ mesenchymal cells are a major component of the intestinal stem cells niche at homeostasis and after injuryIgor Stzepourginski, Giulia Nigro, Jean-Marie Jacob, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2009
Inflammation recapitulates the ontogeny of lymphoid stromal cellsLucie Peduto, Sophie Dulauroy, Matthias Lochner, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Current Pharmaceutical Design|July 16, 2009
ADAM9 as a potential target molecule in cancerLucie Peduto
Current Opinion in Immunology|May 11, 2020
Mesenchymal perivascular cells in immunity and diseaseAdam Benabid, Lucie Peduto
Cell Stem Cell|March 8, 2026
Neuronal VIP shapes intestinal stem cell activity and mucosal immunityCamilla Anastasio, Lucie Peduto
The Journal of Clinical Investigation|January 3, 2018
The perivascular origin of pathological fibroblastsSelene E Di Carlo, Lucie Peduto
Journal of Immunological Methods|January 21, 2015
An optimized protocol for isolating lymphoid stromal cells from the intestinal lamina propriaIgor Stzepourginski, Gérard Eberl, Lucie Peduto
Mucosal Immunology|January 28, 2023
Stromal regulation of the intestinal barrierMarvin Sylvestre, Selene E Di Carlo, Lucie Peduto
Nature Medicine|July 31, 2012
Lineage tracing and genetic ablation of ADAM12(+) perivascular cells identify a major source of profibrotic cells during acute tissue injurySophie Dulauroy, Selene E Di Carlo, Francina Langa, et al.
Cancer Research|October 19, 2005
Critical function for ADAM9 in mouse prostate cancerLucie Peduto, Victor E Reuter, David R Shaffer, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2017
CD34+ mesenchymal cells are a major component of the intestinal stem cells niche at homeostasis and after injuryIgor Stzepourginski, Giulia Nigro, Jean-Marie Jacob, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2009
Inflammation recapitulates the ontogeny of lymphoid stromal cellsLucie Peduto, Sophie Dulauroy, Matthias Lochner, et al.
Pageof 3